Financhill
Buy
65

CASY Quote, Financials, Valuation and Earnings

Last price:
$466.18
Seasonality move :
6.67%
Day range:
$462.65 - $467.79
52-week range:
$313.89 - $470.56
Dividend yield:
0.43%
P/E ratio:
32.56x
P/S ratio:
1.12x
P/B ratio:
4.98x
Volume:
242K
Avg. volume:
405.2K
1-year change:
44.55%
Market cap:
$17B
Revenue:
$14.9B
EPS (TTM):
$14.35

Earnings Data

Next earnings date for CASY
Jun 11
2025
Most recent earnings per share
$2.33
Beat by $0.24
(Mar 11/2025)
Consensus Estimate
$2.09
(Mar 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CASY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/31/2025 Q3 $4.5B -- -- $5.00 --
06/11/2025 Q2 $4B -- -- $1.98 --
03/11/2025 Q1 $3.7B $3.9B $2.33 $2.09 $0.24
12/09/2024 Q4 $4B $3.9B $4.85 $4.29 $0.56
09/04/2024 Q3 $4.1B $4.1B $4.83 $4.51 $0.32
06/11/2024 Q2 $3.5B $3.6B $2.34 $1.72 $0.62
03/11/2024 Q1 $3.5B $3.3B $2.33 $2.14 $0.19
12/11/2023 Q4 -- -- $4.24 $3.76 $0.48
09/11/2023 Q3 -- -- $4.52 $3.36 $1.16
06/06/2023 Q2 -- -- $1.49 $1.64 -$0.15
03/07/2023 Q1 -- -- $2.67 $2.00 $0.67
12/06/2022 Q4 -- -- $3.67 $3.13 $0.54
09/07/2022 Q3 -- -- $4.09 $3.68 $0.41
06/07/2022 Q2 -- -- $1.60 $1.58 $0.02
03/08/2022 Q1 -- -- $1.71 $1.45 $0.26
12/07/2021 Q4 -- -- $2.59 $2.96 -$0.37
09/07/2021 Q3 -- -- $3.19 $3.02 $0.17
06/08/2021 Q2 -- -- $1.12 $0.88 $0.24
03/08/2021 Q1 -- -- $1.04 $1.00 $0.04
12/07/2020 Q4 -- -- $3.00 $2.82 $0.18
09/08/2020 Q3 -- -- $3.24 $2.06 $1.18
06/08/2020 Q2 -- -- $1.67 $1.83 -$0.16
03/09/2020 Q1 -- -- $0.91 $0.89 $0.02
12/09/2019 Q4 -- -- $2.21 $2.15 $0.06
09/09/2019 Q3 -- -- $2.31 $2.01 $0.30
06/10/2019 Q2 -- -- $0.68 $0.52 $0.16
03/11/2019 Q1 -- -- $1.13 -- --
12/11/2018 Q4 -- -- $1.80 -- --
09/10/2018 Q3 -- -- $1.90 -- --
06/12/2018 Q2 -- -- $0.51 -- --
03/07/2018 Q1 -- -- $5.08 -- --
12/12/2017 Q4 -- -- $1.28 -- --
09/06/2017 Q3 -- -- $1.46 -- --
06/05/2017 Q2 -- -- $0.76 -- --
03/07/2017 Q1 -- -- $0.58 -- --
12/08/2016 Q4 -- -- $1.44 -- --
09/07/2016 Q3 -- -- $1.70 -- --
06/07/2016 Q2 -- -- $1.19 -- --
03/07/2016 Q1 -- -- $0.97 -- --
12/07/2015 Q4 -- -- $2.00 -- --
09/09/2015 Q3 -- -- $1.57 -- --

Casey's General Stores Earnings Questions

  • How Much did Casey's General Stores Generate in Revenue Last Quarter?

    Casey's General Stores reported $3.9B worth of top line sales in its most recent quarter.

  • Did Casey's General Stores Beat Earnings Last Quarter?

    Casey's General Stores announced earnings per share of $2.33 which represents a beat of analyst forecast a $2.09 per share.

  • Is Casey's General Stores Profitable?

    Casey's General Stores reported $912.6M that represents $24.43 per share over the last quarter.

  • What is the Analyst Consensus for Casey's General Stores EPS Next Year?

    Casey's General Stores's earnings are forecast to grow from $13.43 per share to $13.99 per share next year representing an increase of 4.45%.

  • When is Casey's General Stores's Earnings Date?

    Casey's General Stores's next earnings date is June 11, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is down 0% over the past day.

Buy
53
SRPT alert for May 7

Sarepta Therapeutics [SRPT] is down 21.54% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock